Peritoneovenous shunt for palliation of gynecologic XXXX .

@entity1 @entity43 @entity1204 @entity1353 @entity5 @entity843 @entity6887 @entity189 @entity344 @entity432
BACKGROUND: Ascites is a common sequela of advanced or recurrent gynecologic @entity5 , such as @entity6887 , or endometrium. Symptomatic treatment with repeated paracentesis is the initial management after failure of chemotherapy. STUDY DESIGN: This study was done to evaluate the safety and effectiveness of a peritoneovenous shunt (PVS) in the palliation of these @entity1 with recurrent @entity843 . A retrospective review of 25 @entity1 having a PVS between 1982 and 1992 was performed. RESULTS: The 25 @entity1 consisted of 21 @entity1 with @entity43 , two with @entity189 of the peritoneum, one with @entity1204 , and one @entity1 with @entity6887 . The mean weight and abdominal girth decreased after shunt insertion (p < 0.001). @entity344 and @entity1353 also improved with PVS insertion. There was no change in mean Karnofsky score after placement of a PVS. Two @entity1 died within ten days postoperatively. The median survival period was 80 days and @entity432 occurred in four @entity1 . CONCLUSIONS: The insertion of a PVS is effective in relieving refractory @entity5 in gynecologic @entity5 . The impact on quality of life requires further study.
